Conference Agenda
Day 1 - Tuesday, April 25, 2023
11:30-11:55: Registration and box lunch — Great Room Foyer
11:55-12:00: Welcome/Opening — Great Room
David Cassak, Editor-in-Chief, MedTech Strategist
Stephen Levin, Editor-in-Chief, Market Pathways
12:00-12:30: Fireside Chat: - Building Great Companies –
Andrew Cleeland, CEO, Fogarty Innovation
David Cassak, Editor-in-Chief, MedTech Strategist (Moderator)
12:35-1:15: Reading the Current M&A Environment: The Bankers’ Perspective
Adam Barker, Head of Healthcare Equity Research, Goodbody
Michael Healy, Director, Healthcare Investment Banking, UBS Healthcare
Kinam Hong, Partner, Sofinnova Partners
Jennie Xue, Senior Managing Director, Guggenheim Securities
David Cassak, Editor-in-Chief, MedTech Strategist (Moderator)
1:20-1:25: Moderator - Medmarc
1:25-1:35: Aortyx
1:35-1:45: LaNua Medical
1:45-1:55: Vitestro
1:55-2:05: Locate Bio
2:05-2:15: TibaRay
2:15-2:25: Fada Medical
2:25-2:35: Triplemed
2:35-3:10: Future Medtech From Ireland:
Stephen Cox, CEO, InVera Medical
Lyn Markey, Co-Founder & CEO, XTremedy Medical
Lucy O’Keeffe, CEO, CroiValve
Elle Sander, Co-Founder & CEO, Lifelet Medical
Alan Hobbs, Manager High Potential Start Ups, Enterprise Ireland (Moderator)
3:10-3:30: Networking Break -- Great Room Foyer
3:30-3:35: Moderator: Greenlight Guru
3:35-4:15: Medtech by the Numbers
Barbara Castellano, Partner, Panakes Partners
Megan MacDonagh, Vice President, SV Health Investors
Rabab Nasrallah, Investment Team, Earlybird Venture Capital
Anne Portwich, Partner, EQT Life Sciences
Jennifer McMahon, Partner, Seroba Life Sciences (Moderator)
4:20-4:30: Integrated Translational Research: Advanced preclinical methods support product differentiation
Peter Markham, President & CEO, CBSET
4:30-4:40: Active Medical
4:40-4:50: ViCentra
4:50-5:00: Samsara Vision
5:00-5:10: TEDIRO
5:10-5:20: Pacertool AS
5:20-5:30: Artiria Medical
5:35-6:35: MedTech Innovator — Dublin
Paul Grand, Founder & CEO, MedTech Innovator
Jake Goble, Cardiac and General Medical Products Business Leader, WL Gore
Jennifer Kozak, Vice President, Business Development, Johnson & Johnson
Rupert Winckler, Head of EMEA Business Development, Olympus Corporation
Edna Lazar, Senior Director, Exploration, Edwards Lifesciences
6:35-7:45: Networking Reception
Day 2 - Wednesday, April 26, 2023
8:00-8:30: Registration & Welcome Coffee — Great Room Foyer
8:30-8:35: Moderator – IQVIA Medtech
8:35-8:45: Microsure
8:45-8:55: Hemerion Therapeutics
8:55-9:05: INBRAIN Neuroelectronics
9:05-9:15: Versono Medical
9:15-9:25: Altavo
9:25-10:00: Keynote: Medtech 2023, Where Do We Go From Here?: Medtech trends and implications from EY’s annual Pulse of the Industry survey
Todd Brinton, MD, Chief Scientific Officer and Corporate Vice President, Edwards and Board of Stanford Biodesign
Jennifer Kozak, Vice President, Business Development, Johnson & Johnson
Fergal McAleavey, Partner and Head of Corporate Finance, EY
John Babitt, Partner, EY, (Moderator)
10:00-10:40: Investing in Late/Growth Capital
Janke Dittmer, Partner, Gilde Healthcare
Ruben Osnabrugge, Investment Manager, EQT Life Sciences
Daniel Parera, Partner, Kurma Partners
Alexander Schmitz, Partner, Endeavour Vision
David Cassak, Editor-in-Chief, MedTech Strategist (Moderator)
10:40-11:00: Networking Break — Great Room Foyer
11:00-11:40: Building a Great Board: Criteria and Compensation Considerations
Sophie Baratte, Managing Director, Agile Capital Markets
Chuck Carignan, Executive Chairman, Cairdac
Reinhard Krickl, CEO, Phagenesis
Martin Pfister, Principal, High-Tech Gründerfonds Management
Agata Lindenthal, Senior Consultant, HTI Healthcare and Technology International (Moderator)
11:40-12:10: Keynote: Christopher Cleary, Senior Vice President of Corporate Development, Medtronic
12:10-12:50: Panel Session Reimbursement: Getting Paid for Innovative Technologies
Arjun Desai, Chief Strategic Innovation Officer, Insightec
Ronan Glynn, Partner, Health Sector Lead, EY
Dan Rose, CEO, LimFlow
Stephen Levin, Editor-in-Chief, Market Pathways
12:50-2:00: Lunch
2:00-2:45: Current Investment Trends and Dynamics from a European perspective:
Arthur Franken, General Partner, Gilde Healthcare
Mano Iyer, Partner, Sofinnova Partners
Olivier Litzka, Partner, Andera Partners
Thom Rasche, Managing Partner, Earlybird Venture Capital
David Cassak, Editor-in-Chief, MedTech Strategist (Moderator)
2:50-2:55: Moderator — Velentium
2:55-3:05: BlueDrop Medical
3:05-3:15: Positrigo
3:15-3:25: Ronovo Surgical
3:25-3:35: Azalea Vision
3:35-3:45: Alucent Biomedical
3:45-4:05: Networking Break — Great Room Foyer
4:05-4:45: MDR: Are We Still Talking About This? And What Does It Mean for the Future?
Oliver Bisazza, CEO, Medtech Europe
Claire Dyson, Consultant/former Head of UK Approved Body at DEKRA
Pedro Eerdmans, Director, Global Strategy Services, NAMSA
Sinead Keogh, Director, Ibec MedTech & Engineering, Ibec
Stephen Levin, Editor-in-Chief, Market Pathways
4:50-4:55: Moderator — Team Consulting
4:55-5:05: Dianosic
5:05-5:15: Ceroflo
5:15-5:25: Oxford Endovascular
5:30-6:00: Q & A — Perspective From Experiences Building Start-ups to Strategic
Todd Brinton, MD, Chief Scientific Officer and Corporate Vice President, Edwards and Board of Stanford Biodesign
David Cassak, Editor-in-Chief, MedTech Strategist (Moderator)
6:00-7:30: Networking Reception
Day 3 - Thursday, April 27, 2023
8:00-8:20: Registration & Welcome Coffee — Great Room Foyer
8:20-9:10: Future Proofing Innovation in a Medtech Sprint
Kevin Boyle, SVP R&D Interventional, BD
Jinny Lee, SVP of Exploration, Strategy and Marketing, Edwards Lifesciences
Sinead Walsh, Director of Operations, BioInnovate
Ashley Seehusen, Venture Partner, Sante Ventures and COO, Sante Accel
Fiachra Sweeney, CTO, Fire1
Lisa Carmel, EVP Global Strategic Partnerships, Veranex (Moderator)
9:15-9:55: US investors in Europe The New Global Perspective
Auriel August, Senior Associate, Santé
Janke Dittmer, Partner, Gilde Healthcare
Caroline Gaynor, Partner, Lightstone Ventures
Andy McGibbon, Managing Partner Sonder Capital
Théophile Mohr Durdez, CEO, Volta Medical
David Cassak, Editor-in-Chief, MedTech Strategist (Moderator)
10:00-10:40: Rationalizing the Portfolio in a Changing Medtech Environment:
Christopher Cleary, Senior Vice President of Corporate Development, Medtronic
Virginia Giddings, Vice President Exploration, Edwards Lifesciences
Jennifer Kozak, Vice President, Business Development, Johnson & Johnson
Rupert Winckler, Head of EMEA Business Development, Olympus Corporation
David Cassak, Editor-in-Chief, MedTech Strategist (Moderator)
10:40-11:20: Getting in the Endzone: Achieving Commercialisation
Isabella Schmitt, Director of Regulatory Affairs, Proxima Clinical Research
Michalis Papadakis, Founder & CEO, Brainomix
Ross O’Neil, Founder & CEO, Neuromod Devices
Donal O'Shea, Founder & CEO, Deciphex
John Olden, Partner, Addleshaw Goddard (Moderator)
11:20-12:00: What would a China opportunity look like for you?
Olivier d’Arros, Managing Partner, Mavie Technologies
Lucien Goffart, CEO, Robocath
Jose Calle Gordo, Chairman, Highlife Medical and Board member of JenaValve
Jack Qian, CEO, Alfa Medtech
Stephen Levin, Editor-in-Chief, Market Pathways (moderator)
12:00-12:20: Networking Break & Working Box Lunch — Great Room Foyer
12:20-12:25: Moderator – Vicky Valla, Regulatory Compliance Lead, Evnia
12:25-12:35: PreciHealth
12:35-12:45: Intressa Vascular
12:45-12:55: BresoTec Medical
12:55-1:05: Sentante
1:05-1:15: inHEART
1:15-1:25: FluidAI
1:30-2:10: The Real World Impact of MDR: How CEOs and Investors are Adapting
Bernard Collins, Chairman, Aerogen
James Eadie, Managing Director, Sante Ventures
Florian Ludwig, CEO, CardiacBooster and Venture Partner, Thuja Capital
John O’Dea, CEO, Palliare
Stephen Levin, Editor-in-Chief, Market Pathways
2:10: Event concludes